Two target segments. The Multi-user Rely meter will be directed toward nursing homes, group diabetes/endocrine practices, clinics, and diabetic school children while at school, where more than one patient will be tested using the same meter. The second target for Rely At-Home users will be low end diabetics, those who are uninsured, under-insured and those insured that do not want to pay high co-pays.

DECN is counting on a single partner who shares the same view of the markets, where DECN can concentrate on Amazon, Walmart and other on-line sites, and the partner can make GenAccord a low end retail product.

And what makes this essentially "me too" product a major step ahead? The foil wrapped test strips. DECN can create a "to go" pack. A second meter and a wafer of foil wrapped test strips. But who really cares, products and a business are meaningless, its all about and only about share price. And....


By the way weav take a look at the meter below. Look familiar?


http://www.gl-diabetes.com/product_cloudia.html

KB worked on this concept in 2014 and 2015. Remember Discretion Messenger? Could it be coming back?